Blood Borne Virus
-
Hepatitis B Virus Genotype
-
Hepatitis C Virus Genotype
-
Hepatitis E Virus
-
Human Immunodeficiency Virus I
Central Nervous System
-
Meningitis / Encephalitis (ME)
Gastrointestinal Diseases
-
Viral: Norovirus GI, Norovirus GII, Adenovirus Type 41, Rotavirus, Astrovirus, Sapovirus
-
Bacterial-Parasite: Campylobacter jejuni, Campylobacter lari, Clostridium difficile 027, Shigella flexneri, Salmonella enteritidis,
-
Yersinia enterolitica, Giardia lamblia, Cryptosporidium parvum, Entamoeba histolytica, Plesiomonas shigelloides
-
Pathogenic E. coli: E.coli 0157, Shiga toxin-producing E.coli, Enterotoxigenic E.coli
Respiratory Diseases
-
INFA - H1N1, INFA - H3N2, INFB - Victoria, RSV - Type A, RSV - Type B
Sexual Transmitted Diseases
-
Trichomonas vaginalis
-
Mycoplasma genitalium
-
Mycoplasma hominis
-
Ureaplasma urealyticum
-
Gardnerella vaginalis
-
Neisseria gonorrhoea
-
Chlamydia trachomatis
-
Fungal Infection
-
Candida spp
-
Aspergillus spp
Evaluation Panels
Verification and Validation panels are designed to evaluate and establish the assay parameters of the molecular method and determine its fitness for purpose: Used for verification and validation of clinical assays, development of diagnostic tests and training of laboratory personnel. Designed to confirm any performance claims and suitability for the laboratories testing requirements. Where appropriate, calibrated against a WHO International Standard or Internal Reference Material, all quantified by digital PCR. These panels contain a 3 panel linearity series and also a duplicate sample. Some of these panels also contain different genotypes – as it varies by panel.
QCMD Past Panels
QCMD past panels are highly characterised Quality Assessment materials that have been used within previous QCMD International EQA / PT schemes. They are extremely helpful in post EQA evaluations and provide an additional source of quality material. Qnostics as a distribution partner of QCMD, is able to provide the EQA panel materials and accompanying EQA summaries to customers outside of the active QCMD EQA programmes once they have closed.